Protein-rich Diet and NAFLD in Bariatric Surgery
Protein-rich Diet and Non-Alcoholic Fatty Liver Disease in Bariatric Surgery
1 other identifier
interventional
60
1 country
1
Brief Summary
Randomized, single-blind, trial to determine whether a high-protein, low calorie diet is more effective than a control low calorie diet in improving the metabolic and histologic abnormalities in patients with Non-alcoholic Fatty Liver Disease undergoing bariatric surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable obesity
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 23, 2015
CompletedFirst Posted
Study publicly available on registry
March 26, 2015
CompletedStudy Start
First participant enrolled
June 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2016
CompletedMarch 26, 2015
March 1, 2015
1 year
March 23, 2015
March 23, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
Liver fat content assessment
1 year
Secondary Outcomes (2)
Insulin sensitivity assessment
1 year
fat free mass assessment
1 year
Study Arms (2)
High-protein low calorie diet (HPLC)
ACTIVE COMPARATOR900 Kcal; Protein 90 g (39%); CHO 75 g (30%); Lipid 32 g (31%)
Control low calorie diet (CLC)
PLACEBO COMPARATOR900 Kcal; Protein. 50 g (22%); CHO 119 g (48%); Lipid 31 g (30%)
Interventions
Eligibility Criteria
You may qualify if:
- Morbidly obese subjects with a BMI \>40 kg/m2 who are eligible for bariatric surgery and have accepted to undergo RYGB
- Weight stable for at least 6 months before the study (+/- 5 kg within the previous 6 months)
- Stable medication
- Provision of informed consent
You may not qualify if:
- Patients not eligible for laparoscopic RYGB
- Incapacity to give a valid informed consent or unwilling to give the consent
- Pregnancy or lactating
- Type 2-diabetes mellitus
- Significant illness within the two weeks preceding surgery, as judged by the physician.
- Obvious infection (bacteria, virus etc)
- Major cardiovascular disease
- Major gastrointestinal, respiratory, or any hormonal disorders
- History of drug addiction and/or alcohol use
- Suspected or confirmed poor compliance
- Alcohol consumption of \> 20 g per day in the case of women and \> 30 g per day in the case of men for at least 3 consecutive months during the previous 5 years
- Presence of hepatitis C or frank cirrhosis.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Catholic University of the Sacred Heartlead
- Federico II Universitycollaborator
Study Sites (1)
Catholic University School of Medicine
Rome, 00168, Italy
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
March 23, 2015
First Posted
March 26, 2015
Study Start
June 1, 2015
Primary Completion
June 1, 2016
Last Updated
March 26, 2015
Record last verified: 2015-03